Home / Energy Alternative Sources / Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Published: Apr 2015 | No Of Pages: 89 | Published By: GlobalData

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Exocrine Pancreatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Exocrine Pancreatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Exocrine Pancreatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Exocrine Pancreatic Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Exocrine Pancreatic Insufficiency 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Abbott Laboratories 33
Clinical Trial Overview of Abbott Laboratories 33
Forest Laboratories, Inc. 35
Clinical Trial Overview of Forest Laboratories, Inc. 35
Digestive Care, Inc. 36
Clinical Trial Overview of Digestive Care, Inc. 36
DATAMAP GmbH 37
Clinical Trial Overview of DATAMAP GmbH 37
Parexel International Corporation 38
Clinical Trial Overview of Parexel International Corporation 38
Anthera Pharmaceuticals‚ Inc. 39
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 39
LAL Clinica Pesquisa e Desenvolvimento Ltda 40
Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimento Ltda 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Axcan Pharma Inc. 42
Clinical Trial Overview of Axcan Pharma Inc. 42
AbbVie Inc. 43
Clinical Trial Overview of AbbVie Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44
Clinical Trial Overview of Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44
The Foundation for Liver Research 45
Clinical Trial Overview of The Foundation for Liver Research 45
University of Pennsylvania 46
Clinical Trial Overview of University of Pennsylvania 46
Azienda Ospedaliera Universitaria Integrata Verona 47
Clinical Trial Overview of Azienda Ospedaliera Universitaria Integrata Verona 47
Calvary Mater Newcastle 48
Clinical Trial Overview of Calvary Mater Newcastle 48
Columbia University 49
Clinical Trial Overview of Columbia University 49
Seattle Children's Hospital 50
Clinical Trial Overview of Seattle Children's Hospital 50
Sheffield Teaching Hospitals NHS Foundation Trust 51
Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 51
Texas A&M University 52
Clinical Trial Overview of Texas A&M University 52
The University of Tokyo 53
Clinical Trial Overview of The University of Tokyo 53
Five Key Clinical Profiles 54
Appendix 87
Abbreviations 87
Definitions 87
Research Methodology 88
Secondary Research 88
About GlobalData 89
Contact Us 89
Disclaimer 89
Source 89

List of Tables
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exocrine Pancreatic Insufficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Exocrine Pancreatic Insufficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Exocrine Pancreatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 33
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 35
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Digestive Care, Inc., 2015* 36
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by DATAMAP GmbH, 2015* 37
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Parexel International Corporation, 2015* 38
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2015* 39
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LAL Clinica Pesquisa e Desenvolvimento Ltda, 2015* 40
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 41
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Axcan Pharma Inc., 2015* 42
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo, 2015* 44
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Foundation for Liver Research, 2015* 45
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 46
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Integrata Verona, 2015* 47
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Calvary Mater Newcastle, 2015* 48
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 49
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2015* 50
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2015* 51
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas A&M University, 2015* 52
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 53

List of Figures
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 88

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +